We therefore examined the levels of anti-Spike RBD antibodies in subjects with a family history of cardiovascular disease and found no difference with those in subjects with no family history of cardiovascular disease (P = 0.482; Fig. S1F). This evidence concerns the gene CHMP5 and cardiovascular disorder.